NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Zhejiang Hisoar Pharmaceutical Co., Ltd. Says it will boost 260 million yuan in its Jiangsu-based bio-medicine unit. Says it will also use 3 million yuan to buy the rest 2 percent stake in the bio-medicine unit. Says the co will hold 100 percent stake in the unit and the unit…

news

Drug firm Natco Pharma has received final approval from the US health regulator for generic version of Budesonide capsules used for treatment of active Crohn's disease for the American market. The company has received "final approval of abbreviated new drug application (ANDA) from the US Food and Drug Administration (USFDA)…

Thursday, Nov 24, 2016
news

Aurobindo Pharma, Cadila, Mcleods Pharmaceuticals are among the 39 Indian drug companies that have been blacklisted by Vietnam for quality standard violations. The Vietnamese drug regulator has also banned companies in Bangladesh and South Korea. The regulator has listed the names of blacklisted companies on its website without specifying in…

news

Daehan New Pharm Co Ltd Says it will buy 1,000 shares of Baverstock GmbH, which is engaged in oil development investment in Kazakhstan, to maximize overseas investment value. Says transaction amount is 8.07 billion won. Says it will hold 30 percent stake(6,000 shares) in Baverstock GmbH, after the transaction.  …

news

Drug maker Cipla’s UK arm sold the entire 16.7% stake it held in Chase Pharma, a US-based clinical-stage biopharmaceutical company, to Allergan, famous for its Botox brand, the drug maker said. Cipla had first picked a 14.6% stake in Chase for $1.5 million investment in 2014, via a syndicated venture,…

news

Wockhardt Ltd Says USFDA has issued a warning letter to C P Pharmaceuticals Limited, Wrexham, United Kingdom, a stepdown subsidiary of the company. Says currently, there is no business being conducted from C P Pharmaceuticals to the US market. C P Pharma has initiated required steps to address concerns raised…

news

U.S. officials have given a green light for two clinical trials testing AstraZeneca's cancer immunotherapy drug durvalumab in head and neck cancer to resume recruiting patients, lifting a hold imposed following cases of bleeding. The British drugmaker said on Tuesday that one of the late-stage Phase III trials had already…

news

Sun Pharma, today announced the execution of definitive agreements by its wholly owned subsidiary, for the acquisition of 85.1% of JSC Biosintez, a Russian pharmaceutical company engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region. The equity consideration for the 85.1% stake is US$ 24 million.…

news

Sanofi receives FDA approval of Soliqua(tm) 100/33, for the treatment of adults with type 2 diabetes. Says Soliqua 100/33 will be available in U.S. retail pharmacies in January 2017.   Source : reuters.com

news

Respiratorius AB Says has received Orphan Drug Designation for its drug candidate VAL001 for treatment of diffuse large b-cell lymphoma following decision by European Commission. Will obtain market exclusivity for ten years in EU, from date of marketing approval, and free consultation and scientific advice on contact with the European…